SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-270735
Filing Date
2024-12-04
Accepted
2024-12-04 16:38:27
Documents
2
Group Members
FREDERICK V. FORTMILLER, JRHARRADEN CIRCLE INVESTORS GP, LLCHARRADEN CIRCLE INVESTORS GP, LPHARRADEN CIRCLE INVESTORS, LPHARRADEN CIRCLE SPECIAL OPPORTUNITIES, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d900537dsc13ga.htm SC 13G/A 107384
2 EX-99.1 d900537dex991.htm EX-99.1 6489
  Complete submission text file 0001193125-24-270735.txt   115751
Mailing Address 299 PARK AVE 21ST FLOOR NEW YORK NY 10171
Business Address 299 PARK AVE 21ST FLOOR NEW YORK NY 10171 212 832 4111
Harraden Circle Investments, LLC (Filed by) CIK: 0001910592 (see all company filings)

IRS No.: 813057945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1
Business Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1 27744604171
PSYENCE BIOMEDICAL LTD. (Subject) CIK: 0001985062 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-94325 | Film No.: 241526688
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)